News from the AGA
News from the AGA
Every day you benefit from innovations made possible by GI research
News from the AGA
Impact of the AGA Research Foundation
News from the AGA
VIDEO: Vedolizumab may benefit Crohn’s patients who fail anti-TNF therapy
Key clinical point: Vedolizumab seems to take longer than 6 weeks to work in patients with moderately to severely active Crohn’s disease. Major...